Article Information
History
- May 31, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Constantine Vardavas1,
- Konstantinos Zisis1,2,
- Katerina Nikitara1,
- Ioanna Lagou1,
- Katerina Aslanoglou1,
- Kostas Athanasakis2,
- Revati Phalkey3,
- Jo Leonardi-Bee3,
- Esteve Fernandez4,
- Orla Condell5,
- Favelle Lamb5,
- Frank Sandmann5,
- Anastasia Pharris5,
- Charlotte Deogan5 and
- Jonathan E. Suk5,*
- 1School of Medicine, University of Crete, Heraklion, Greece
- 2Department of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece
- 3Centre for Evidence Based Healthcare, School of Medicine, University of Nottingham, Nottingham, UK
- 4Catalan Institute of Oncology, Barcelona, Spain
- 5European Centre for Disease Prevention and Control (ECDC)
- ↵*Corresponding Author:
Jonathan Suk PhD, European Centre for Disease Prevention and Control (ECDC), Gustav III:s boulevard 40, 169 73 Solna, Sweden, Phone +46 (0)8 58 60 10 00 / Fax +46 (0)8 58 60 10 01, Email: jonathan.suk{at}ecdc.europa.eu
Posted May 31, 2022.
The cost of the COVID-19 pandemic vs the cost-effectiveness of mitigation strategies in the EU/UK/EEA and OECD countries: a systematic review
